Peterson Katharine
Acrivon Therapeutics, Inc. Common Stock · Chief Accounting Officer
Peterson Katharine is listed in filings as Chief Accounting Officer at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including 11 public disclosures. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV). The current snapshot covers public activity from Aug 16, 2024 to May 20, 2026. Reported amounts are shown as $190 to $189. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||